Emerging Microbes & Infections

Article	Citations
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan	2110
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes	1285
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody	982
Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients	875
Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors	764
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2	584
Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia	581
Laboratory diagnosis of emerging human coronavirus infections – the state of the art	543
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension	468
Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26	454
RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak	408
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists	386
Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients	371
Identification of novel mobile colistin resistance gene mcr-10	315
Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity	308
Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019)	292
A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses	277
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells	266
ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens	266
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron	265
COVID-19 pandemic – an African perspective	265
Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost	263
Clinical observation and management of COVID-19 patients	261
Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient	250
Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction	249

Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2	241
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies	232
The different clinical characteristics of corona virus disease cases between children and their families in China – the character of children with COVID-19	232
A serological survey of SARS-CoV-2 in cat in Wuhan	223
Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients	208
Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation	205
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells	192
SARS-CoV-2 infection, disease and transmission in domestic cats	188
Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case–control real-world study	187
Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic	175
Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection	168
Patterns of IgG and IgM antibody response in COVID-19 patients	160
SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species	144
Experimental aerosol survival of SARS-CoV-2 in artificial saliva and tissue culture media at medium and high humidity	142
Antibody titres decline 3-month post-vaccination with BNT162b2	137
Short- and potential long-term adverse health outcomes of COVID-19: a rapid review	126
Thein vitroantiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor	121
Risks and features of secondary infections in severe and critical ill COVID-19 patients	121
Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine	119
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection	115
High neutralizing antibody titer in intensive care unit patients with COVID-19	114
Antibodies in the breast milk of a maternal woman with COVID-19	112
Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates	110
SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East	108
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells	107
Emergence and spread of novel H5N8, H5N5 and H5N1 clade 2.3.4.4 highly pathogenic avian influenza in 2020	107
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)	106
Diagnosis and clinical management of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection: an operational recommendation of Peking Union Medical College Hospital (V2.0)	104
Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets	100
Genotype I African swine fever viruses emerged in domestic pigs in China and caused chronic infection	97
Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2	97
Susceptibility of rabbits to SARS-CoV-2	96
SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease	92
Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture	90
Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies	88
Non-active antibiotic and bacteriophage synergism to successfully treat recurrent urinary tract infection caused by extensively drug-resistant Klebsiella pneumoniae	88
Risk factors associated with COVID-19 infection: a retrospective cohort study based on contacts tracing	87
Next-generation pathogen diagnosis with CRISPR/Cas-based detection methods	86
Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters	85
Serological differentiation between COVID-19 and SARS infections	82
Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2	79
The first discovery of severe fever with thrombocytopenia syndrome virus in Taiwan	77
Diagnostic value and key features of computed tomography in Coronavirus Disease 2019	77
Susceptibility of swine cells and domestic pigs to SARS-CoV-2	74
Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity	73
Timely development of vaccines against SARS-CoV-2	71
The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections	71
Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus	70
Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients	68
Lessons learned from the fifth wave of COVID-19 in Hong Kong in early 2022	67

Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study	67
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	65
Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine	64
Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned	61
Social distancing: how religion, culture and burial ceremony undermine the effort to curb COVID-19 in South Africa	61
Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China, 2008–2018	61
A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners	60
Emergence of ST11-K47 and ST11-K64 hypervirulent carbapenem-resistant Klebsiella pneumoniae in bacterial liver abscesses from China: a molecular, biological, and epidemiological study	60
Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19	58
Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines	57
Deficiency of HIF-1α enhances influenza A virus replication by promoting autophagy in alveolar type II epithelial cells	57
Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population	55
Co-existence of a novel plasmid-mediated efflux pump with colistin resistance gene mcr in one plasmid confers transferable multidrug resistance in Klebsiella pneumoniae	55
Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine	54
Infection and transmission of ancestral SARS-CoV-2 and its alpha variant in pregnant white-tailed deer	54
Novel dual multiplex real-time RT-PCR assays for the rapid detection of SARS-CoV-2, influenza A/B, and respiratory syncytial virus using the BD MAX open system	53
Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression	53
Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19	53
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies	53
African swine fever control and prevention: an update on vaccine development	50
Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients	50
Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?	50
Competing endogenous RNA network profiling reveals novel host dependency factors required for MERS-CoV propagation	50
Meta-analysis of diagnostic performance of serology tests for COVID-19: impact of assay design and post-symptom-onset intervals	50
SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates	49
Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission	49
Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model	48
Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study	48
Animal models for emerging coronavirus: progress and new insights	47
Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities	47
Zoonotic and reverse zoonotic events of SARS-CoV-2 and their impact on global health	46
Significance of serology testing to assist timely diagnosis of SARS-CoV-2 infections: implication from a family cluster	46
High estradiol and low testosterone levels are associated with critical illness in male but not in female COVID-19 patients: a retrospective cohort study	45
Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture	45
Perception of the 2020 SARS-CoV-2 pandemic among medical professionals in Germany: results from a nationwide online survey	45
Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis	44
Global dissemination of H5N1 influenza viruses bearing the clade 2.3.4.4b HA gene and biologic analysis of the ones detected in China	44
Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach	43
Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction via TMPRSS2 activation of membrane fusion	43
A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates	43
Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries	42
The interplay between emerging human coronavirus infections and autophagy	42
Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target	41
Emerging colistin resistance inSalmonella entericaserovar Newport isolates from human infections	41
Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge	41
Identification of novel tetracycline resistance gene tet(X14) and its co-occurrence with tet(X2) in a tigecycline-resistant and colistin-resistant Empedobacter stercoris	41
Colistin-resistance gene mcr in clinical carbapenem-resistant Enterobacteriaceae strains in China, 2014–2019	41
Mathematic modeling of COVID-19 in the United States	40
Evolution and extensive reassortment of H5 influenza viruses isolated from wild birds in China over the past decade	40
Experimental re-infected cats do not transmit SARS-CoV-2	40
Excretion of SARS-CoV-2 through faecal specimens	40
Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: an algorithm-based method for overcoming resistance to antiviral agents	40
Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications	39
Metformin attenuated sepsis-related liver injury by modulating gut microbiota	39
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2	39
Identification of a novel lineage bat SARS-related coronaviruses that use bat ACE2 receptor	39
Resistance evolution of hypervirulent carbapenem-resistant Klebsiella pneumoniae ST11 during treatment with tigecycline and polymyxin	39
COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue	39
Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study	38
Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial	38
Novel H5N6 reassortants bearing the clade 2.3.4.4b HA gene of H5N8 virus have been detected in poultry and caused multiple human infections in China	38
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection	38
The ongoing COVID-19 epidemic in Minas Gerais, Brazil: insights from epidemiological data and SARS-CoV-2 whole genome sequencing	37
Clostridioides difficile infection in the Asia-Pacific region	37
Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells	37
Comparative pathogenicity and environmental transmission of recent highly pathogenic avian influenza H5 viruses	37
An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics	37
Plasma miRNA profile at COVID-19 onset predicts severity status and mortality	37
Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018	36
A novel DNA and protein combination COVID-19 vaccine formulation provides full protection against SARS-CoV-2 in rhesus macaques	36
The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants	36
Co-circulation of two SARS-CoV-2 variant strains within imported pet hamsters in Hong Kong	36
Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort	36
Laboratory management for SARS-CoV-2 detection: a user-friendly combination of the heat treatment approach and rt-Real-time PCR testing	36
Advances in detection of infectious agents by aptamer-based technologies	36
Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study	35
Penaeidins restrict white spot syndrome virus infection by antagonizing the envelope proteins to block viral entry	35
Loss of orf3b in the circulating SARS-CoV-2 strains	35
Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster	35
HIV-1 did not contribute to the 2019-nCoV genome	35

A novel SARS-CoV-2 related coronavirus with complex recombination isolated from bats in Yunnan province, China	35
Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents	35
Cytotoxin-producing Klebsiella oxytoca in the preterm gut and its association with necrotizing enterocolitis	34
Molecular epidemiology of carbapenem-resistant hypervirulent Klebsiella pneumoniae in China	34
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan	34
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern in real-world: a literature review and meta-analysis	34
Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors	33
An open, prospective cohort study of VV116 in Chinese participants infected with SARS-CoV-2 omicron variants	33
Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site	33
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV	33
Susceptibility of livestock to SARS-CoV-2 infection	33
Severity of SARS-CoV-2 Omicron BA.2 infection in unvaccinated hospitalized children: comparison to influenza and parainfluenza infections	33
SARS-CoV-2 reinfection and COVID-19 severity	32
The preclinical inhibitor GS441524 in combination with GC376 efficaciously inhibited the proliferation of SARS-CoV-2 in the mouse respiratory tract	31
Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response	31
Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study	31
Low incidence of airborne SARS-CoV-2 in acute care hospital rooms with optimized ventilation	31
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection	31
Detection of breastmilk antibodies targeting SARS-CoV-2 nucleocapsid, spike and receptor-binding-domain antigens	31
No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2	31
Swine acute diarrhea syndrome coronavirus-induced apoptosis is caspase- and cyclophilin D- dependent	30
Public’s early response to the novel coronavirus–infected pneumonia	30
Confirmation of fifth Candida auris clade by whole genome sequencing	30
Aetiology of severe community acquired pneumonia in adults identified by combined detection methods: a multi-centre prospective study in China	30
Viral loads in throat and anal swabs in children infected with SARS-CoV-2	30
Impact of population movement on the spread of 2019-nCoV in China	30
Tropism, pathology, and transmission of equine parvovirus-hepatitis	30
Infections with highly pathogenic avian influenza A virus (HPAIV) H5N8 in harbor seals at the German North Sea coast, 2021	29
Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma	29
Cointegration as a mechanism for the evolution of a KPC-producing multidrug resistance plasmid in Proteus mirabilis	29
L-lysine potentiates aminoglycosides against Acinetobacter baumannii via regulation of proton motive force and antibiotics uptake	28
Alarming situation of emerging H5 and H7 avian influenza and effective control strategies	28
The type I-E CRISPR-Cas system influences the acquisition of blaKPC-IncF plasmid in Klebsiella pneumonia	28
ATP-binding cassette (ABC) import systems of Mycobacterium tuberculosis: target for drug and vaccine development	28
SARS-CoV-2 genomic characterization and clinical manifestation of the COVID-19 outbreak in Uruguay	28
Mapping the global potential transmission hotspots for severe fever with thrombocytopenia syndrome by machine learning methods	28
Antibodies to SARS-CoV-2 in dogs and cats, USA	28
Tick-borne encephalitis foci in northeast Italy revealed by combined virus detection in ticks, serosurvey on goats and human cases	28
Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis	27
Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays	27
The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China	27
Long-term follow-up of Helicobacter pylori reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational study	27
Wild boar harbouring African swine fever virus in the demilitarized zone in South Korea, 2019	27
Modelling Toxoplasma gondii infection in human cerebral organoids	27
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response	26
Isolation and characterization of a duck-origin goose astrovirus in China	26
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants	26
Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study	26
Methicillin-resistant Staphylococcus aureus in China: a multicentre longitudinal study and whole-genome sequencing	26
Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection	25
Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models	25
Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France	25
Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model	25
Trypsin promotes porcine deltacoronavirus mediating cell-to-cell fusion in a cell type-dependent manner	25
Possible recombination between two variants of concern in a COVID-19 patient	25
Increasing prevalence of hypervirulent ST5 methicillin susceptible Staphylococcus aureus subtype poses a serious clinical threat	24
Metagenomic next-generation sequencing in the family outbreak of psittacosis: the first reported family outbreak of psittacosis in China under COVID-19	24
Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry	24
Increased temperatures reduce the vectorial capacity of Aedes mosquitoes for Zika virus	24
Genomic epidemiology of emerging ESBL-producing Salmonella Kentucky blaCTX-M-14b in Europe	24
Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021	24
Backtracking and forward checking of human listeriosis clusters identified a multiclonal outbreak linked to Listeria monocytogenes in meat products of a single producer	24
Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022	24
Epidemiology and clinical course of COVID-19 in Shanghai, China	23
Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo	23
Prevalence of hypervirulent and carbapenem-resistant Klebsiella pneumoniae under divergent evolutionary patterns	23
mRNA and miRNA profiling of Zika virus-infected human umbilical cord mesenchymal stem cells identifies miR-142-5p as an antiviral factor	23
Omicron: a drug developer’s perspective	23
Identification of chicken CAR homology as a cellular receptor for the emerging highly pathogenic fowl adenovirus 4 via unique binding mechanism	23
A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses	23
Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave	23
CRISPR-based platform for carbapenemases and emerging viruses detection using Cas12a (Cpf1) effector nuclease	22
Prior aerosol infection with lineage A SARS-CoV-2 variant protects hamsters from disease, but not reinfection with B.1.351 SARS-CoV-2 variant	22
Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination	22
Molecular characterization, receptor binding property, and replication in chickens and mice of H9N2 avian influenza viruses isolated from chickens, peafowls, and wild birds in eastern China	22
Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern	22
Molecular characterization of carbapenem-resistant and virulent plasmids in Klebsiella pneumoniae from patients with bloodstream infections in China	22
Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification	22
A porcine macrophage cell line that supports high levels of replication of OURT88/3, an attenuated strain of African swine fever virus	21
Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine	21
Comprehensive literature review of monkeypox	21
Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination	21
Corticosteroid prevents COVID-19 progression within its therapeutic window: a multicentre, proof-of-concept, observational study	21
Emergence of colistin-resistant hypervirulent Klebsiella pneumoniae (CoR-HvKp) in China	21
Prolonged presence of viral nucleic acid in clinically recovered COVID-19 patients was not associated with effective infectiousness	21
Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants	21
Roles of lncRNAs in influenza virus infection	21
Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study	21
Saliva viral load better correlates with clinical and immunological profiles in children with coronavirus disease 2019	21
Balamuthia mandrillaris infection in China: a retrospective report of 28 cases	21
Compensatory effects of M. tuberculosis rpoB mutations outside the rifampicin resistance-determining region	20
Brucella melitensis, a latent “travel bacterium,” continual spread and expansion from Northern to Southern China and its relationship to worldwide lineages	20
Dissemination and genome analysis of high-level ceftriaxone-resistant penA 60.001 Neisseria gonorrhoeae strains from the Guangdong Gonococ	20
An IncP-2 plasmid sublineage associated with dissemination of blaIMP-45 among carbapenem-resistant Pseudomonas aeruginosa	20
Direct neuronal infection of SARS-CoV-2 reveals cellular and molecular pathology of chemosensory impairment of COVID-19 patients	20
Diagnosing Balamuthia mandrillaris encephalitis via next-generation sequencing in a 13-year-old girl	20
Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients	20
Human Borna disease virus 1 (BoDV-1) encephalitis cases in the north and east of Germany	20
Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study	20
Multiple detection and spread of novel strains of the SARS-CoV-2 B.1.177 (B.1.177.75) lineage that test negative by a commercially available nucleocapsid gene real-time RT-PCR	20
SARS-CoV-2 pseudovirus enters the host cells through spike protein-CD147 in an Arf6-dependent manner	20
Genetic manipulation of porcine deltacoronavirus reveals insights into NS6 and NS7 functions: a novel strategy for vaccine design	20
The prevalence of CRF55_01B among HIV-1 strain and its connection with traffic development in China	20
A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice	19
PB1 S524G mutation of wild bird-origin H3N8 influenza A virus enhances virulence and fitness for transmission in mammals	19
Jamestown Canyon virus in Massachusetts: clinical case series and vector screening	19
COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia	19
The potassium transporter KdpA affects persister formation by regulating ATP levels in Mycobacterium marinum	19
PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255	19
Safety, mucosal and systemic immunopotency of an aerosolized adenovirus-vectored vaccine against SARS-CoV-2 in rhesus macaques	19
Misdiagnosis of imported falciparum malaria from African areas due to an increased prevalence of pfhrp2/pfhrp3 gene deletion: the Djibouti case	19
Generation of neutralizing and non-neutralizing monoclonal antibodies against H7N9 influenza virus	19
Active and prospective latent tuberculosis are associated with different metabolomic profiles: clinical potential for the identification of rapid and non-invasive biomarkers	19
Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates	19
Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis	19
Development of an automatic integrated gene detection system for novel severe acute respiratory syndrome-related coronavirus (SARS-CoV2)	19
Pig as a reservoir of CRISPR type TST4 Salmonella enterica serovar Typhimurium monophasic variant during 2009–2017 in China	18
Hypoxia reduces cell attachment of SARS-CoV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan sulfate	18
MERTK is a host factor that promotes classical swine fever virus entry and antagonizes innate immune response in PK-15 cells	18
The combination of salvianolic acid A with latamoxef completely protects mice against lethal pneumonia caused by methicillin-resistant Staphylococcus aureus	18
Mink is a highly susceptible host species to circulating human and avian influenza viruses	18
A new nairo-like virus associated with human febrile illness in China	18
Households as hotspots of Lassa fever? Assessing the spatial distribution of Lassa virus-infected rodents in rural villages of Guinea	18
Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV	18
Competition between Usutu virus and West Nile virus during simultaneous and sequential infection of Culex pipiens mosquitoes	18
A second functional furin site in the SARS-CoV-2 spike protein	18
COVID-19 in children across three Asian cosmopolitan regions	18
Heterologous boosting with third dose of coronavirus disease recombinant subunit vaccine increases neutralizing antibodies and T cell immunity against different severe acute respiratory syndrome coron	18
Emergence of new phylogenetic lineage of Influenza D virus with broad antigenicity in California, United States	18
Genomic epidemiology of Candida auris in a general hospital in Shenyang, China: a three-year surveillance study	17
Live attenuated coronavirus vaccines deficient in N7-Methyltransferase activity induce both humoral and cellular immune responses in mice	17
Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus	17
A novel Sporothrix brasiliensis genomic variant in Midwestern Brazil: evidence for an older and wider sporotrichosis epidemic	17
Yin-Yang 1 and HBx protein activate HBV transcription by mediating the spatial interaction of cccDNA minichromosome with cellular chromosome 19p13.11	17
Nurse infected with Covid-19 from a provisional dengue patient	17
Epidemiology of COVID-19 in Brazil: using a mathematical model to estimate the outbreak peak and temporal evolution	17
Modulation of lethal HPAIV H5N8 clade 2.3.4.4B infection in AIV pre-exposed mallards	17
Co-existence of OXA-48 and NDM-1 in colistin resistant Pseudomonas aeruginosa ST235	17
Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract	17
Subtype distribution of zoonotic pathogen Cryptosporidium felis in humans and animals in several countries	17
Widely heterogeneous humoral and cellular immunity after mild SARS-CoV-2 infection in a homogeneous population of healthy young men	17
Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate	16
Establishing a high sensitivity detection method for SARS-CoV-2 IgM/IgG and developing a clinical application of this method	16
A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain)	16
Molecular investigation of infection sources and transmission chains of brucellosis in Zhejiang, China	16

Super-dominant pathobiontic bacteria in the nasopharyngeal microbiota as causative agents of secondary bacterial infection in influenza patients	16
Prevalence and risk analysis of mobile colistin resistance and extended-spectrum β-lactamase genes carriage in pet dogs and their owners: a population based cross-sectional study	16
Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistance	16
Emergence of the novel SARS-CoV-2 lineage VUI-NP13L and massive spread of P.2 in South Brazil	16
First report of Rickettsia felis in mosquitoes, USA	16
Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein	16
Identification of a novel bacterial receptor that binds tail tubular proteins and mediates phage infection of Vibrio parahaemolyticus	16
Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination	16
Novel tigecycline resistance mechanisms in Acinetobacter baumannii mediated by mutations in adeS, rpoB and rrf	16
Susceptibility of sheep to experimental co-infection with the ancestral lineage of SARS-CoV-2 and its alpha variant	16
SARS-CoV-2 IgG seropositivity after the severe Omicron wave of COVID-19 in Hong Kong	16
Characterization of highly virulent community-associated methicillin-resistant Staphylococcus aureus ST9-SCCmec XII causing bloodstream infection in China	16
Live bird markets as evolutionary epicentres of H9N2 low pathogenicity avian influenza viruses in Korea	15
Metagenomic analysis of the lung microbiome in pulmonary tuberculosis - a pilot study	15
DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B	15
Re-emergence of H5N8 highly pathogenic avian influenza virus in wild birds, China	15
Will a new clade of SARS-CoV-2 imported into the community spark a fourth wave of the COVID-19 outbreak in Hong Kong?	15
Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal	15
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19	15
Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy	15
Oligonucleotide-capped nanoporous anodic alumina biosensor as diagnostic tool for rapid and accurate detection of Candida auris in clinical samples	15
Non-walled spherical Acinetobacter baumannii is an important type of persister upon β-lactam antibiotic treatment	15
Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial	15
Metabolomic analysis reveals potential biomarkers and the underlying pathogenesis involved in Mycoplasma pneumoniae pneumonia	15
Three doses of an inactivation-based COVID-19 vaccine induces cross-neutralizing immunity against the SARS CoV-2 Omicron variant	15
Serological investigation of asymptomatic cases of SARS-CoV-2 infection reveals weak and declining antibody responses	15
Seroprevalence of human brucellosis and molecular characteristics of Brucella strains in Inner Mongolia Autonomous region of China, from 2012 to 2016	15
Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations	15
IFITM3 affects the level of antibody response after influenza vaccination	15
Infectivity and pathogenicity of different hepatitis E virus genotypes/subtypes in rabbit model	15
Genetically distinct pestiviruses pave the way to improved classical swine fever marker vaccine candidates based on the chimeric pestivirus concept	14
Dysregulation of Ephrin receptor and PPAR signaling pathways in neural progenitor cells infected by Zika virus	14
Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants	14
Viromes and surveys of RNA viruses in camel-derived ticks revealing transmission patterns of novel tick-borne viral pathogens in Kenya	14
Outer membrane vesicles-transmitted virulence genes mediate the emergence of new antimicrobial-resistant hypervirulent Klebsiella pneumoniae	14
Animal alphacoronaviruses found in human patients with acute respiratory illness in different countries.	14
Emergence of multidrug-resistant Mycobacterium tuberculosis of the Beijing lineage in Portugal and Guinea-Bissau: a snapshot of moving clones by whole-genome sequencing	14
Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial	14
RT-LAMP assay for rapid detection of the R203M mutation in SARS-CoV-2 Delta variant	14
Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers	14
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2	14
Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants	14
Understanding the impact of rapid antigen tests on SARS-CoV-2 transmission in the fifth wave of COVID-19 in Hong Kong in early 2022	14
Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants	14
Molecular characterization and epidemiological aspects of non-polio enteroviruses isolated from acute flaccid paralysis in Brazil: a historical series (2005–2017)	14
Spatial and temporal patterns of dengue incidence in Bhutan: a Bayesian analysis	14
Ezrin is essential for the entry of Japanese encephalitis virus into the human brain microvascular endothelial cells	14
Introduction and spread of variegated squirrel bornavirus 1 (VSBV-1) between exotic squirrels and spill-over infections to humans in Germany	14
Hepatitis B virus nucleocapsid uncoating: biological consequences and regulation by cellular nucleases	14
The first detection of Anaplasma capra, an emerging zoonotic Anaplasma sp., in erythrocytes	14
Delayed recognition of Ebola virus disease is associated with longer and larger outbreaks	14
Identifying optimal capsid duplication length for the stability of reporter flaviviruses	14
Isolation of SARS-CoV-2 strains carrying a nucleotide mutation, leading to a stop codon in the ORF 6 protein	14
Tick-borne encephalitis virus NS4A ubiquitination antagonizes type I interferon-stimulated STAT1/2 signalling pathway	13
Viral determinants that drive Enterovirus-A71 fitness and virulence	13
Emergence, prevalence, and evolution of H5N8 avian influenza viruses in central China, 2020	13
Prevalence and transmission characteristics of Listeria species from ruminants in farm and slaughtering environments in China	13
Infection dynamics of Salmonella Infantis strains displaying different genetic backgrounds – with or without pESI-like plasmid – vary considerably	13
Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii	13
The emerging tick-borne pathogen Neoehrlichia mikurensis: first French case series and vector epidemiology	13
Vibrio pore-forming leukocidin activates pyroptotic cell death via the NLRP3 inflammasome	13
Genomic and pathogenic investigations of Streptococcus suis serotype 7 population derived from a human patient and pigs	13
Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus	13
ATP2, The essential P4-ATPase of malaria parasites, catalyzes lipid-stimulated ATP hydrolysis in complex with a Cdc50 β-subunit	13
Exploring surface water as a transmission medium of avian influenza viruses – systematic infection studies in mallards	13
A SARS-CoV-2 variant with the 12-bp deletion at E gene	13
Organizing a COVID-19 triage unit: a Swiss perspective	13
Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody	13
Berbamine inhibits Japanese encephalitis virus (JEV) infection by compromising TPRMLs-mediated endolysosomal trafficking of low-density lipoprotein receptor (LDLR)	13
Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro	13
Do acute hepatopancreatic necrosis disease-causing PirABVP toxins aggravate vibriosis?	13
Highly pathogenic avian influenza (A/H5N1) virus outbreaks in Lesotho, May 2021	13
A new microtubule-stabilizing agent shows potent antiviral effects against African swine fever virus with no cytotoxicity	13
Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study	12
Population structure-guided profiling of antibiotic resistance patterns in clinical Listeria monocytogenes isolates from Germany identifies pbpB3 alleles associated with low levels of ce	12
Emerging highly pathogenic avian influenza (H5N8) virus in migratory birds in Central China, 2020	12
A novel diagnostic test to screen SARS-CoV-2 variants containing E484K and N501Y mutations	12
Impact of the gonococcal FC428 penA allele 60.001 on ceftriaxone resistance and biological fitness	12
Molecular characterization of chikungunya virus during the 2019 outbreak in the Democratic Republic of the Congo	12
UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates	12
Incorporation of information diffusion model for enhancing analyses in HIV molecular surveillance	12
Emergence of oxacillinase-181 carbapenemase-producing diarrheagenic Escherichia coli in Ghana	12
Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China	12
Identification of a new strain of mouse kidney parvovirus associated with inclusion body nephropathy in immunocompromised laboratory mice	12
The activation of antiviral RNA interference not only exists in neural progenitor cells but also in somatic cells in mammals	12
Rheumotologitsts’ view on the use of hydroxychloroquine to treat COVID-19	12
In vitro activity of the first-in-class triazaacenaphthylene gepotidacin alone and in combination with doxycycline against drug-resistant and -susceptible Mycoplasma genitalium	12
Novel pathogenic characteristics of highly pathogenic avian influenza virus H7N9: viraemia and extrapulmonary infection	12
Invasive listeriosis outbreaks and salmon products: a genomic, epidemiological study	12
Where are the RNA vaccines for TB?	12
The impact of the SARS-CoV-2 pandemic on the prevalence of respiratory tract pathogens in patients with community-acquired pneumonia in Germany	12
Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in Singapore	12
Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection in vitro	12
The burden, admission, and outcome of COVID-19 in Africa: protocol for a systematic review and meta-analysis	11
Establishing and applying an adaptive strategy and approach to eliminating malaria: practice and lessons learnt from China from 2011 to 2020	11
Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test	11
Comparative analysis of genomic characteristics, fitness and virulence of MRSA ST398 and ST9 isolated from China and Germany	11
Discovery of novel fungal species and pathogens on bat carcasses in a cave in Yunnan Province, China	11
Characterization of neurotropic HPAI H5N1 viruses with novel genome constellations and mammalian adaptive mutations in free-living mesocarnivores in Canada	11
Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice	11
CqsA/LuxS-HapR Quorum sensing circuit modulates type VI secretion system VflT6SS2 in Vibrio fluvialis	11
Two novel human coronavirus OC43 genotypes circulating in hospitalized children with pneumonia in China	11
Trends in prevalence and incidence of scabies from 1990 to 2017: findings from the global Burden of disease study 2017	11
Stabilized diverse HIV-1 envelope trimers for vaccine design	11
Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation	11
Real-time monitoring of Pseudomonas aeruginosa biofilm growth dynamics and persister cells’ eradication	11
A multi-family cluster of COVID-19 associated with asymptomatic and pre-symptomatic transmission in Jixi City, Heilongjiang, China, 2020	11
HIV-1 CRF07_BC transmission dynamics in China: two decades of national molecular surveillance	11
Host-dependent editing of SARS-CoV-2 in COVID-19 patients	11
Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS	11
Using molecular transmission networks to understand the epidemic characteristics of HIV-1 CRF08_BC across China	11
Mycobacterium tuberculosisESX-1-secreted substrate protein EspC promotes mycobacterial survival through endoplasmic reticulum stress-mediated apoptosis	11
Healthy outcomes of patients with COVID-19 two years after the infection: a prospective cohort study	11
Env diversity-dependent protection of the attenuated equine infectious anaemia virus vaccine	11
Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV	11
Increased inflammation with crude E. coli LPS protects against acute leptospirosis in hamsters	11
Characterization of an NDM-5-producing hypervirulent Klebsiella pneumoniae sequence type 65 clone from a lung transplant recipient	11
A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters	11
Frequent convergence of mcr-9 and carbapenemase genes in Enterobacter cloacae complex driven by epidemic plasmids and host incompatibility	11
A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter	11
Zika structural genes determine the virulence of African and Asian lineages	11
Maternal CMV seroprevalence rate in early gestation and congenital cytomegalovirus infection in a Chinese population	11
Monosubstituted tricationic Zn(II) phthalocyanine enhances antimicrobial photodynamic inactivation (aPDI) of methicillin-resistant Staphylococcus aureus (MRSA) and cytotoxicity evaluation for t	10
Two fatal cases of plague after consumption of raw marmot organs	10
Restoration of a functional antiviral immune response to chronic HBV infection by reducing viral antigen load: if not sufficient, is it necessary?	10
African swine fever virus – variants on the rise	10
A single-amino-acid mutation at position 225 in hemagglutinin attenuates H5N6 influenza virus in mice	10
MCR-1-dependent lipid remodelling compromises the viability of Gram-negative bacteria	10
The Protection of Naturally Acquired Antibodies Against Subsequent SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis	10
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses	10
Blood transcriptomics to characterize key biological pathways and identify biomarkers for predicting mortality in melioidosis	10
Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARS-CoV-2 infection	10
Identification of hepatitis C virus in the common bed bug – a potential, but uncommon route for HCV infection?	10
Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China	10
Molecular characteristics of eae-positive clinical Shiga toxin-producing Escherichia coli in Sweden	10
SARS-CoV-2 infection and disease outcomes in non-human primate models: advances and implications	10
The genetic feature and virulence determinant of highly virulent community-associated MRSA ST338-SCCmec Vb in China	10
Mining of linear B cell epitopes of SARS-CoV-2 ORF8 protein from COVID-19 patients	10
Mutations in porin LamB contribute to ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae	10
HIV-1 pseudoviruses constructed in China regulatory laboratory	10
Human Borna disease virus 1 encephalitis shows marked pro-inflammatory biomarker and tissue immunoactivation during the course of disease	10
The COVID-19-designated hospitals in China: preparing for public health emergencies	10
Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Bra	10
One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization	10
Experimental and field investigations of exposure, replication and transmission of SARS-CoV-2 in pigs in the Netherlands	10
Return of the founder Chikungunya virus to its place of introduction into Brazil is revealed by genomic characterization of exanthematic disease cases	10
Mutational characterization of HBV reverse transcriptase gene and the genotype-phenotype correlation of antiviral resistance among Chinese chronic hepatitis B patients	10
Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection	10
Clade distribution of Candida auris in South Africa using whole genome sequencing of clinical and environmental isolates	10
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China	10
Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled tria	10
Induction of amphotericin B resistance in susceptible Candida auris by extracellular vesicles	10
STAT2-dependent restriction of Zika virus by human macrophages but not dendritic cells	9
High population-attributable fractions of traditional risk factors for non-AIDS-defining diseases among people living with HIV in China: a cohort study	9
Unexpected rabies variant identified in kinkajou (Potos flavus), Mato Grosso, Brazil	9
Molecular epidemiology and genotype-specific disease severity of hepatitis E virus infections in Germany, 2010–2019	9
Seroprevalence of AIH-related autoantibodies in patients with acute hepatitis E viral infection: a prospective case–control study in China	9
Genomic evolution and virulence association of Clostridioides difficile sequence type 37 (ribotype 017) in China	9
Host–pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella	9
A CRISPR/Cas12a-based DNAzyme visualization system for rapid, non-electrically dependent detection of Bacillus anthracis	9
A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants	9
In vivo expressed biologics for infectious disease prophylaxis: rapid delivery of DNA-based antiviral antibodies	9
The widespread presence of a family of fish virulence plasmids in Vibrio vulnificus stresses its relevance as a zoonotic pathogen linked to fish farms	9
Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai	9
IMB-XMA0038, a new inhibitor targeting aspartate-semialdehyde dehydrogenase of Mycobacterium tuberculosis	9
Single-cell analysis of arthritogenic alphavirus-infected human synovial fibroblasts links low abundance of viral RNA to induction of innate immunity and arthralgia-associated gene expression	9
Mapping the risk distribution of Borrelia burgdorferi sensu lato in China from 1986 to 2020: a geospatial modelling analysis	9
Potential role of vector-mediated natural selection in dengue virus genotype/lineage replacements in two epidemiologically contrasted settings	9
Changes in the characteristics and outcomes of COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study	9
mRNA based vaccines provide broad protection against different SARS-CoV-2 variants of concern	9
Human infection with avian-origin H5N6 influenza a virus after exposure to slaughtered poultry	9
Rational development of multicomponent mRNA vaccine candidates against mpox	9
Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2	9
Identification of pyrvinium pamoate as an anti-tuberculosis agent in vitro and in vivo by SOSA approach amongst known drugs	9
Persistence of SARS-CoV-2 neutralizing antibodies longer than 13 months in naturally infected, captive white-tailed deer ( Odocoileus virginianus ), Texas	9
WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20–22 April 2021	9
Trained immunity contributes to the prevention ofMycobacterium tuberculosisinfection, a novel role of autophagy	9
Status of occupational protection in the COVID-19 Fangcang Shelter Hospital in Wuhan, China	9
Generation and characterization of genetically and antigenically diverse infectious clones of dengue virus serotypes 1–4	9
Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model	9
Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters	9
Unbiased metagenomic next-generation sequencing of blood from hospitalized febrile children in Gabon	8
Detection of Crimean Congo haemorrhagic fever virus in North-eastern Senegal, Bokidiawé 2019	8
Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2	8
Antigenic and molecular characterization of low pathogenic avian influenza A(H9N2) viruses in sub-Saharan Africa from 2017 through 2019	8
Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection	8
Assessing the effects of a two-amino acid flexibility in the Hemagglutinin 220-loop receptor-binding domain on the fitness of Influenza A(H9N2) viruses	8
Effective phage cocktail to combat the rising incidence of extensively drug-resistant Klebsiella pneumoniae sequence type 16	8
Chinese tree shrew: a permissive model for in vitro and in vivo replication of human adenovirus species B	8
Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants	8
First detection of highly pathogenic H5N6 avian influenza virus on the African continent	8
A novel oral rabies vaccine enhances the immunogenicity through increasing dendritic cells activation and germinal center formation by expressing U-OMP19 in a mouse model	8
Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques	8
Identification of CKD, bedridden history and cancer as higher-risk comorbidities and their impact on prognosis of hospitalized Omicron patients: a multi-centre cohort study	8
Inoculation route-dependent Lassa virus dissemination and shedding dynamics in the natural reservoir – Mastomys natalensis	8
Trends of pulmonary fungal infections from 2013 to 2019: an AI-based real-world observational study in Guangzhou, China	8
Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models	8
Multiple recombinant events in human T-cell Leukemia virus Type 1: complete sequences of recombinant African strains	8
Genetic characterization of the first detected human case of low pathogenic avian influenza A/H9N2 in sub-Saharan Africa, Senegal	8
Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination	8